App is temporarily unavailable
Description
N/A
Screenshots
Loading...
Please wait..
うつ病の体験談や克服方法が読める - うつケア FAQ
-
Is うつ病の体験談や克服方法が読める - うつケア free?
Yes, うつ病の体験談や克服方法が読める - うつケア is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is うつ病の体験談や克服方法が読める - うつケア legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does うつ病の体験談や克服方法が読める - うつケア cost?
うつ病の体験談や克服方法が読める - うつケア is free.
-
What is うつ病の体験談や克服方法が読める - うつケア revenue?
To get estimated revenue of うつ病の体験談や克服方法が読める - うつケア app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Thailand yet.
Ratings History
うつ病の体験談や克服方法が読める - うつケア Reviews
App doesn't have any reviews yet
うつ病の体験談や克服方法が読める - うつケア Installs
Last 30 days
うつ病の体験談や克服方法が読める - うつケア Revenue
Last 30 daysうつ病の体験談や克服方法が読める - うつケア Revenue and Downloads
Gain valuable insights into うつ病の体験談や克服方法が読める - うつケア performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Unknown
- Languages
- Japanese
- Recent release
- 1.0.3 (2 years ago )
- Released on
- Aug 20, 2022 (2 years ago )
- Also available in
- Japan , United States , New Zealand , Netherlands , Mexico , South Korea , Australia , India , Greece , Egypt , Algeria , Sweden , China , Thailand , Canada , Russia , Poland , Philippines , Peru , Türkiye , Taiwan , Italy , Norway , Israel , France , Finland , Spain , Germany , Chile , Switzerland , Brazil , Azerbaijan
- Last Updated
- 1 year ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.